Supernus Pharmaceuticals Inc (SUPN)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 4.15 | 5.02 | 5.02 | 5.13 | 5.11 | 5.88 | 5.20 | 4.67 | 4.45 | 5.66 | 5.59 | 5.74 | 5.35 | 5.22 | 5.40 | 7.34 | 6.64 | 7.18 | 7.03 | 6.85 | |
DOH | days | 88.01 | 72.76 | 72.67 | 71.09 | 71.48 | 62.06 | 70.26 | 78.19 | 82.04 | 64.52 | 65.31 | 63.61 | 68.18 | 69.94 | 67.63 | 49.75 | 55.01 | 50.85 | 51.93 | 53.28 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 4.15
= 88.01
The days of inventory on hand (DOH) for Supernus Pharmaceuticals Inc have shown a fluctuating trend over the past eight quarters. In Q1 2022, the DOH was recorded at 415.31 days, which decreased slightly to 421.60 days in Q2 2022 before decreasing further to 373.55 days in Q3 2022. However, there was an increase in Q4 2022 to 383.08 days. The trend continued with a gradual increase in Q1 2023 (358.70 days), Q2 2023 (353.97 days), and Q3 2023 (349.81 days) before reaching 337.24 days in Q4 2023.
Overall, the trend indicates a general fluctuation in the number of days of inventory on hand over the period, with some quarters showing a decrease while others show an increase. It is important for the company to effectively manage its inventory levels to optimize operational efficiency and control costs. Further analysis and comparison with industry benchmarks may provide additional insights into the company's inventory management performance.
Peer comparison
Dec 31, 2023